- Approval Id
- 676c8b3a3ce9dbf8
- Drug Name
- VISIPAQUE INJECTION 270 MGI/ML
- Product Name
- VISIPAQUE INJECTION 270 MGI/ML
- Approval Number
- SIN08882P
- Approval Date
- 1996-08-28
- Registrant
- GE HEALTHCARE PTE. LTD.
- Licence Holder
- GE HEALTHCARE PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- INJECTION
- Dosage
- <p><strong>Posology and method of administration</strong></p>
<p>The dosage may vary depending on the type of examination, the age, weight, cardiac output and general condition of the patient and the technique used. Usually approximately the same iodine concentration and volume is used as with other iodinated X-ray contrast media in current use, but adequate diagnostic information has also been obtained in some studies with iodixanol injection with somewhat lower iodine concentration. Adequate hydration should be assured before and after administration as for other contrast media. The product is for intravenous, intra-arterial and intrathecal use.</p>
<p>The following dosages may serve as a guide. The doses given for intra-arterial use are for single injections that may be repeated.</p>
<img src="/TGIF/Visipaque-Table1_240823.png" alt="Visipaque Dosage Table 1" /><br><br>
<p><strong>Elderly: As for other adults</strong></p>
- Route Of Administration
- INTRAVENOUS, INTRA-ARTERIAL, INTRATHECAL
- Indication Info
- <p><strong>Indications</strong></p>
<p>X-ray contrast medium for cardioangiography, cerebral angiography (conventional), peripheral arteriography (conventional), abdominal angiography (i.a. DSA), urography, venography, CT- enhancement. Lumbar, thoracic and cervical myelography.</p>
- Contraindications
- <p><strong>Contraindications</strong></p>
<p>Hypersensitivity to the active substance or to any of the excipients.</p>
<p>Manifest thyrotoxicosis.</p>
- Atc Code
- V08AB09
- Atc Item Name
- iodixanol
- Pharma Manufacturer Name
- GE HEALTHCARE PTE. LTD.
